Spots Global Cancer Trial Database for A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy
Official Title: A Phase I/II Clinical Study Using Pentamidine in Patients With Locally Advanced or Metastatic Pancreatic Cancer Undergoing Standard Therapy
Study ID: NCT00810953
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to investigate the safety and possible efficacy of the use of pentamidine in the treatment of pancreatic cancer metastasis in subjects receiving standard therapy.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
McGill University, Montreal, Quebec, Canada
Contact Details
Name: Petr Kavan, MD, Ph.D.
Affiliation: McGill University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
